InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-4.6%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Ferenczy William J., Vice-Président Senior, Unité Cardio/Métabolique. Officer active across 1 company, notably QUIDEL CORP. Aggregated, 12 filings have been logged. History available since 3 May 2021. The latest transaction was disclosed on 30 March 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
8,683 sharesCommon StockSEC:0000899243-22-020392:0
434 shares0Common StockSEC:0001209191-22-022100:0
652 shares0Common StockSEC:0001209191-22-007624:0
652 shares0Common StockSEC:0001209191-22-007624
473 shares0Common StockSEC:0001209191-22-006634:0
473 shares0Common StockSEC:0001209191-22-006634
1,727 shares0Common StockSEC:0001209191-22-003877
1,727 shares0Common StockSEC:0001209191-22-003877:0
2,000 shares0Common StockSEC:0001209191-21-041179
2,000 shares0Common StockSEC:0001209191-21-041179:0
803 shares@ US$23.4150.0% of flowCommon StockSEC:0001209191-21-030120
803 shares@ US$23.410.0022% mcap50.0% of flowCommon StockSEC:0001209191-21-030120:0
12 of 12 declarations
About Ferenczy William J.
William J. Ferenczy is Senior Vice President of the Cardio/Metabolic Unit at QUIDEL CORP /DE/. In this role, he oversees operations related to health and research in the cardio-metabolic field. His expertise in the medical sector enables him to lead innovation and product improvement initiatives. He plays a key role in the company's growth strategy.
